Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,71 USD | -10,00% | -16,18% | +34,65% |
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 11,08 mln. 10,36 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -23 mln. -21,51 mln. | Nettowinst (verlies) 2025 * | -27 mln. -25,25 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-0,96
x | K/w-verhouding 2025 * |
-1,27
x | Werknemers | 9 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 86,15% |
Recentste transcriptie over Inhibikase Therapeutics, Inc.
1 dag | -10,00% | ||
1 week | -16,18% | ||
Lopende maand | -20,83% | ||
1 maand | -25,33% | ||
3 maanden | -42,23% | ||
6 maanden | +103,57% | ||
Lopend jaar | +34,65% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Milton Werner
FOU | Founder | 61 | 01-09-08 |
C. Warren Olanow
CTO | Chief Tech/Sci/R&D Officer | - | 04-01-21 |
Surendra Singh
COO | Chief Operating Officer | - | 01-04-14 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Dennis Berman
BRD | Director/Board Member | 73 | 01-09-19 |
Paul Grint
BRD | Director/Board Member | 66 | 22-12-20 |
Milton Werner
FOU | Founder | 61 | 01-09-08 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 1,71 | -10,00% | 98 983 |
25-04-24 | 1,9 | +1,60% | 21 668 |
24-04-24 | 1,87 | +18,35% | 62 249 |
23-04-24 | 1,58 | +15,33% | 79 090 |
22-04-24 | 1,37 | -32,84% | 369 205 |
uitgestelde koers Nasdaq, 26 april 2024 om 22:30 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+34,65% | 11,08 mln. | |
+1,51% | 42,75 mld. | |
+8,57% | 41,34 mld. | |
+49,22% | 41,61 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |